IMP3 Is a novel prognostic marker that correlates with colon cancer progression and pathogenesis

Annals of Surgical Oncology

Volumn 16, Issue 12, 2009, Pages 3499-3506

  Li, Dawei ^a   Yan, Dongwang ^a   Tang, Huamei ^a   Zhou, Chongzhi ^a   Fan, Junwei ^a   Li, Shuxia ^a   Wang, Xiaoliang ^a   Xia, Jun ^a   Huang, Fei ^a   Qiu, Guoqiang ^a   Peng, Zhihai ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; MESSENGER RNA; SOMATOMEDIN BINDING PROTEIN 3;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; COLON CANCER; COLON CARCINOGENESIS; COLON RESECTION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; COLON; COLONIC NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA-BINDING PROTEINS; SURVIVAL RATE; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 71549131285     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-009-0648-5     Document Type: Article

References (31)

1. SJ Baker ER Fearon JM Nigro, et al. 1989 Chromosome 1 deletions and p53 gene mutations in colorectal carcinomas Science. 244 217 221 10.1126/science.2649981 1:CAS:528:DyaL1MXit12gt74%3D 2649981
2. PJ Morin AB Sparks V Korinek N Barker H Clevers B Vogelstein KW Kinzler 1997 Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC Science. 275 1787 1790 10.1126/science.275.5307.1787 1:CAS:528:DyaK2sXitVGrtL0%3D 9065402 (Pubitemid 27136715)
3. K Forrester C Almoguera K Han WE Grizzle M Perucho 1987 Detection of high incidence of K-ras oncogenes during human colon tumorigenesis Nature. 327 298 303 10.1038/327298a0 1:CAS:528:DyaL2sXktlCht7w%3D 2438556 (Pubitemid 17075080)
4. J Fan Z Peng C Zhou, et al. 2008 Gene-expression profiling in Chinese patients with colon cancer by coupling experimental and bioinformatic genomewide gene-expression analyses: identification and validation of IFITM3 as a biomarker of early colon carcinogenesis Cancer. 113 266 275 10.1002/cncr.23551 1:CAS:528:DC%2BD1cXpt1OrsLc%3D 18470904
5. J Nielsen J Christiansen J Lykke-Andersen AH Johnsen UM Wewer FC Nielsen 1999 A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development Mol Cell Biol. 19 1262 1270 1:CAS:528: DyaK1MXhtVKht7s%3D 9891060
6. TM Gress F Mueller-Pillasch M Geng, et al. 1996 A pancreatic cancer-specific expression profile Oncogene. 13 1819 1830 1:CAS:528: DyaK28XmvVShtL0%3D 8895530
7. S Runge FC Nielsen J Nielsen J Lykke-Andersen UM Wewer J Christiansen 2000 H19 RNA binds four molecules of insulin-like growth factor II mRNA binding protein J Biol Chem. 275 29562 29569 10.1074/jbc.M001156200 1:CAS:528: DC%2BD3cXmvFKjsb0%3D 10875929 (Pubitemid 32043834)
8. GA Doyle NA Betz PF Leeds AJ Fleisig RD Prokipcak J Ross 1998 The c-myc coding region determinant-binding protein: a member of a family of KH domain RNA-binding proteins Nucleic Acids Res. 26 5036 5044 10.1093/nar/26.22.5036 1:CAS:528:DyaK1cXnvF2jtLc%3D 9801297
9. B Liao Y Hu DJ Herrick G Brewer 2005 The RNA-binding protein IMP-3 is a translational activator of insulin-like growth factor II leader-3 mRNA during proliferation of human K562 leukemia cells J Biol Chem. 280 18517 18524 10.1074/jbc.M500270200 1:CAS:528:DC%2BD2MXjsl2htbY%3D 15753088 (Pubitemid 41389102)
10. F Mueller-Pillasch B Pohl M Wilda, et al. 1999 Expression of the highly conserved RNA binding protein KOC in embryogenesis Mech Dev. 88 95 99 10.1016/S0925-4773(99)00160-4 1:CAS:528:DyaK1MXmsFaru7Y%3D 10525192 (Pubitemid 29467415)
11. K Yaniv JK Yisraeli 2002 The involvement of a conserved family of RNA binding proteins in embryonic development and carcinogenesis Gene. 287 49 54 10.1016/S0378-1119(01)00866-6 1:CAS:528:DC%2BD38XjtFygt7c%3D 11992722 (Pubitemid 34460566)
12. NA Hammer TO Hansen AG Byskov, et al. 2005 Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and testicular cancer Reproduction. 130 203 212 10.1530/rep.1.00664 1:CAS:528:DC%2BD2MXhtVSksbvJ 16049158 (Pubitemid 41149808)
13. R Simon PA Bourne Q Yang BO Spaulding PA di Sant'Agnese HL Wang H Xu 2007 Extrapulmonary small cell carcinomas express K homology domain containing protein overexpressed in cancer, but carcinoid tumors do not Hum Pathol. 38 1178 1183 10.1016/j.humpath.2007.02.001 1:CAS:528:DC%2BD2sXotVWksbg%3D 17521698 (Pubitemid 47058168)
14. L Gu K Shigemasa K Ohama 2004 Increased expression of IGF II Increased expression of IGF II mRNA-binding protein 1 mRNA is associated with an advanced clinical stage and poor prognosis in patients with ovarian cancer Int J Oncol. 24 671 678 1:CAS:528:DC%2BD2cXitFantLc%3D 14767552
15. RK Yantiss BA Woda GR Fanger, et al. 2005 KOC (K homology domain containing protein overexpressed in cancer): a novel molecular marker that distinguishes between benign and malignant lesions of the pancreas Am J Surg Pathol. 29 188 195 10.1097/01.pas.0000149688.98333.54 15644775 (Pubitemid 40170636)
16. KM Sojka BS Spaulding GK Nielsen SA Dinnogen R Welcher 2006 Immunoreactivity of anti-L523S on normal and malignant lung pleural tissue biopsies Mod Pathol. 18 288A
17. H Xu PA Bourne BO Spaulding HL Wang 2007 High-grade neuroendocrine carcinomas of the lung express K homology domain containing protein overexpressed in cancer but carcinoid tumors do not Hum Pathol. 38 555 563 10.1016/j.humpath.2006.11.011 1:CAS:528:DC%2BD2sXjt1Shtro%3D 17316760 (Pubitemid 46399894)
18. Z Jiang PG Chu BA Woda, et al. 2006 Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal cell carcinoma: a retrospective study Lancet Oncol. 7 556 564 10.1016/S1470-2045(06)70732-X 1:CAS:528: DC%2BD28Xmt1OqsLs%3D 16814207 (Pubitemid 43923666)
19. S Istvanic GR Fanger AE Fraire, et al. 2005 Spectrum of KOC (K homology domain containing protein over-expressed in cancer) immunostaining among carcinomas of different sites Mod Pathol. 18 298A 299A
20. JG Pryor PA Bourne Q Yang BO Spaulding GA Scott H Xu 2008 IMP-3 is a novel progression marker in malignant melanoma Mod Pathol. 21 431 437 10.1038/modpathol.3801016 1:CAS:528:DC%2BD1cXjs1akur0%3D 18204432
21. W Zheng X Yi O Fadare SX Liang M Martel PE Schwartz Z Jiang 2008 The Oncofetal Protein IMP3 A Novel Biomarker for Endometrial Serous Carcinoma Am J Surg Pathol. 32 304 315 10.1097/PAS.0b013e3181483ff8 18223334 (Pubitemid 351172146)
22. NE Hoffmann Y Sheinin CM Lohse AS Parker BC Leibovich Z Jiang ED Kwon 2008 External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma Cancer. 112 1471 1479 10.1002/cncr.23296 18260086
23. F Mueller M Bommer U Lacher, et al. 2003 KOC is a novel molecular indicator of malignancy Br J Cancer. 88 699 701 10.1038/sj.bjc.6600790 1:CAS:528:DC%2BD3sXhs1Crs7c%3D 12618877 (Pubitemid 36411447)
24. JB O'Connell MA Maggard CY Ko 2004 Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging J Natl Cancer Inst. 96 1420 1425 15467030
25. PY Zhuang JB Zhang XD Zhu, et al. 2008 Two pathologic types of hepatocellular carcinoma with lymph node metastasis with distinct prognosis on the basis of CK19 expression in tumor Cancer. 112 2740 2748 10.1002/cncr.23488 18412155 (Pubitemid 351969219)
26. TV Hansen NA Hammer J Nielsen, et al. 2004 Dwarfism and impaired gut development in insulin-like growth factor II mRNA-binding protein 1-deficient mice Mol Cell Biol. 24 4448 4464 10.1128/MCB.24.10.4448-4464.2004 1:CAS:528:DC%2BD2cXjvFChtb0%3D 15121863 (Pubitemid 41071014)
27. KZ Hanley MS Facik PA Bourne Q Yang BO Spaulding TA Bonfiglio H Xu 2008 Utility of anti-L523S antibody in the diagnosis of benign and malignant serous effusions Cancer. 114 49 56 10.1002/cncr.23254 1:CAS:528:DC%2BD1cXktVWrt74%3D 18098206 (Pubitemid 351304612)
28. C Ma Y Rong DR Radiloff, et al. 2008 Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation Genes Dev. 22 308 321 10.1101/gad.1632008 18245446 (Pubitemid 351214273)
29. J Vikesaa TV Hansen L Jønson R Borup UM Wewer J Christiansen FC Nielsen 2006 RNA-binding IMPs promote cell adhesion and invadopodia formation Embo J. 25 1456 1468 10.1038/sj.emboj.7601039 1:CAS:528:DC%2BD28XjtFGqtb0%3D 16541107
30. L Li H Xu BO Spaulding, et al. 2008 Expression of RNA-binding protein IMP3 (KOC) in benign urothelium and urothelial tumors Hum Pathol. 39 1205 1211 10.1016/j.humpath.2007.12.012 1:CAS:528:DC%2BD1cXptVKrs7c%3D 18547613
31. L Sitnikova G Mendese Q Liu, et al. 2008 IMP3 predicts aggressive superficial urothelial carcinoma of the bladder Clin Cancer Res. 14 1701 1706 10.1158/1078-0432.CCR-07-2039 1:CAS:528:DC%2BD1cXjtlejtLs%3D 18347170